Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus
نویسندگان
چکیده
منابع مشابه
Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus.
Pulmonary arterial hypertension (PAH) is a severe manifestation of systemic sclerosis (SSc) and systemic lupus erythematosus (SLE). Due to improvements in the understanding of the pathogenesis of these diseases, improved methodological rigour in the conduct of epidemiological studies and the advent of successful therapies, our understanding of SSc-PAH and SLE-PAH has evolved considerably. In th...
متن کاملNeurobrucellosis in systemic lupus erythematosus
Background: Brucellosis is a zoonotic infection which is endemic in many countries. It is a multisystem disease which may present with a broad spectrum of clinical manifestations and complications. Neurobrucellosis is an uncommon complication of brucellosis. Case presentation: A 25-year-old woman with a history of lupus for 5 months referred to the emergency ward of Shahid Beheshti Hosp...
متن کاملAsymptomatic Pulmonary Hypertension in Systemic Lupus Erythematosus
INTRODUCTION Pulmonary arterial hypertension (PAH) is a serious and often fatal complication of systemic lupus erythematosus (SLE). Because the diagnosis of PAH often is made years after symptom onset, early diagnostic strategies are essential. Doppler echocardiography currently is considered the noninvasive screening test of choice for evaluating pulmonary hypertension. AIM Screening for asy...
متن کاملPulmonary arterial hypertension in systemic lupus erythematosus: should we bother?
Pulmonary arterial hypertension (PAH) in SLE: should we bother? Yes, but, as we shall discuss, only in patients with increased chance to develop this complication. PAH is thought to be a life-threatening complication of CTDs, which is mainly based on reports of patients with SSc. Before advanced therapies became available, the prevalence of PAH in SSc was estimated to be between 7.5 and 12% wit...
متن کاملPulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill.
Pulmonary hypertension in systemic lupus erythematosus (SLE) in the absence of chronic parenchymal lung disease or pulmonary emboli is rare. We report such a case with an acute and rapidly progressive onset of symptoms in a patient who had started taking the contraceptive pill eight months previously.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Respiratory Review
سال: 2011
ISSN: 0905-9180,1600-0617
DOI: 10.1183/09059180.00003811